GENOMICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-02-24 古天乐

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤基础研究
经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。

71 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-10-18 leiou

under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信

77 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-09-15 nwu_majun

reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。

70 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-07-01 lekai726

只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎

77 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-06-17 ms9686134410729756

审稿速度:7.0
经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】

81 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-06-11 ms8838453850558450

审稿速度:12.0
经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。

52 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-06-11 ms4191257501199150

审稿速度:12.0
经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。

94 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-06-01 ms3000046594999774

审稿速度:6.0
经验分享：2楼的小伙伴你的稿件状态怎么样了呀

42 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-06-01 ms2848770090237977

审稿速度:6.0
经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。

44 0

[GetPortalCommentsPageByObjectIdResponse(id=926821, encodeId=0943926821ea, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤基础研究 经验分享：该期刊整体质量还不错，审稿速度2个月一审结束，返修半个月接收。还是比较快的期刊。reviewers的意见比较中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 11:56:04 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892916, encodeId=55ec8929165a, content=under review 4个月了，中间催了一次，回复已经让第2个审稿人1个月内返意见，一个月又过去了，还是杳无音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe9e1607784, createdName=leiou, createdTime=Sun Oct 18 21:06:32 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885380, encodeId=6a678853800e, content=reviewer invited 都2个多月了发信都没有回音的那种。现在这个杂志慢的很了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/77886ae3fd4f441c836576e1c53915db/be6b9b9558564d18b078b667adf060ce.jpg, createdBy=2cd42061085, createdName=nwu_majun, createdTime=Tue Sep 15 08:32:09 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800809, encodeId=776a8008098f, content=只是过来打个酱油，三分变六分，摩托变赛车，这比借壳上市的股票还让人垂涎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Wed Jul 01 18:09:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862048, encodeId=8ea2862048f3, content=审稿速度:7.0 经验分享：回复5楼小伙伴：恭喜呀，不过bmc家的都是要版面费的，我老板不太愿意【笑哭】 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Wed Jun 17 23:39:52 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861732, encodeId=78ff861e3290, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861731, encodeId=6c33861e31f4, content=审稿速度:12.0 经验分享：回复四楼小伙伴：reviewer invited 63天就撤稿了，已转投bmc genomics，现在快要接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072c5414108, createdName=ms4191257501199150, createdTime=Thu Jun 11 10:31:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861289, encodeId=1c9686128953, content=审稿速度:6.0 经验分享：2楼的小伙伴你的稿件状态怎么样了呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Mon Jun 01 20:51:34 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861288, encodeId=486c8612883c, content=审稿速度:6.0 经验分享：under review6个月了，19年11月底投的，五个半月的时候写信给编辑催稿，没有回信，稿件状态依然没有变，不知道什么情况，现在美国疫情严重，很担心编辑出什么事稿件受影响。有小伙伴也有这样的情况么？一起讨论一下呀，等的真的好着急。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Mon Jun 01 20:50:10 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591264, encodeId=c6b3591264b8, content=嗯飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, beContent=飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/21/9118d838e28f0115b013cfb400022707.jpg, createdBy=1e6719005, createdName=cathy916, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 cathy916

嗯飞翔的医学生 2020-04-20 00:00:00 发表:
请问现在under review了吗？

飞翔的医学生 2020-04-20 00:00:00 发表: 请问现在under review了吗？

66 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务